|
JAMA Network Open |
Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma |
1 |
Yes |
11/24/2024 |
|
JAMA Network Open |
Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden |
1 |
Yes |
12/21/2024 |
|
AMA Journal of Ethics |
Roles of Environmental Services Workers' Wages and Status in Patient Safety |
1 |
Yes |
9/1/2025 |
|
AMA Journal of Ethics |
Roles of Graphic Pathographies in Clinical Training |
1 |
Yes |
1/23/2027 |
|
JAMA Network Open |
Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron Variant |
1 |
Yes |
5/31/2025 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Saddle-Nose Deformity in the Setting of Diffuse Cutaneous Lesions in an African American Man |
1 |
Yes |
7/21/2025 |
|
JAMA Network Open |
Safety and Adverse Events Among Long-term Care Residents Receiving a Third COVID-19 mRNA Vaccine Booster Dose in Quebec |
1 |
Yes |
8/1/2025 |
|
JAMA Network Open |
Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant |
1 |
Yes |
9/17/2024 |
|
JAMA Network Open |
Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant |
1 |
Yes |
9/17/2024 |
|
JAMA Dermatology |
Safety and Effectiveness of Oral Nutraceuticals for Treating Acne - A Systematic Review |
1 |
Yes |
10/25/2024 |
|
JAMA Network Open |
Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic |
1 |
Yes |
8/30/2024 |
|
JAMA Network Open |
Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic |
1 |
Yes |
8/30/2024 |
|
JAMA Internal Medicine |
Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose |
1 |
Yes |
8/4/2024 |
|
JAMA Surgery |
Safety of Combined Division vs Separate Division of the Splenic Vein in Patients Undergoing Distal Pancreatectomy |
1 |
Yes |
5/12/2024 |
|
JAMA Neurology |
Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures |
1 |
Yes |
7/8/2024 |
|
JAMA Network Open |
SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria |
1 |
Yes |
10/26/2025 |
|
JAMA Internal Medicine |
SARS-CoV-2 Antibody Response After ChAdOx1 nCoV-19 Vaccination in Persons With Previous SARS-CoV-1 Infection |
1 |
Yes |
1/26/2025 |
|
JAMA Oncology |
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents |
1 |
Yes |
1/14/2025 |
|
JAMA Network Open |
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine |
1 |
Yes |
8/19/2024 |
